MSB 1.86% $1.32 mesoblast limited

Cell Therapy News/Articles, page-16742

  1. 3,978 Posts.
    lightbulb Created with Sketch. 1368
    We have very little data that the EU would except. Our last P3 was US based and as such the EU would first want FDA approval before considering that data for approval. Same as we see with Takeda were they first got EU approval and now are doing trials in the US.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.